The SoPD blog has done a substantial post on this paper. I think this is because this discovery reveals another way by which the elimination/reduction of alpha-synuclein aggregates could be neuroprotective. The blog post includes some information on the alpha-synuclein immunotherapy trials of AFFiRiS and Prothena, and even a few words (in the comments section) on the ongoing CliniCrowd mannitol trial.
NB: Like a lot of SoPD posts, this one starts with a largely unrelated preamble. The actual post begins after the line (in bold) "What does this have to do with Parkinson's".
Written by
jeffreyn
To view profiles and participate in discussions please or .
Thank you for posting this. I am wondering about the calcium blocker, Israpidine, that is used to lower blood pressure, is relevant to this discussion. Leading me to ask: We are 2 years into this 3 year trial and I have no intel on how it is going, not even anecdotal. I would love to hear from anyone taking israpidine. I would also love to hear from anyone in the know if israpidine is related to blocking the SERCA protein. If it is why aren't we hearing more about israpidine I wonder.
I really like the post. Briefly, Calcium is critical to our ability to function. It plays a fundamental role in our central nervous system. There is a lot of evidence to suggest that calcium is somehow involved in Parkinson’s. From epidemiological research suggesting that people taking calcium channel blockers have a lower risk of developing Parkinson’s to postmortem analysis of indicating changes in calcium in the brains of people with Parkinson’s.
Basically, the thinking is that over-active calcium channels could stress and potentially kill dopamine-producing cells. This is what the Clinical Trial: STEADY-PD III is investigating ‘Isradipine’ (tradenames DynaCirc, Prescal). can Isradipine slow the progression of PD by keeping the brain’s dopamine-producing cells healthy?
I can't wait for the study to complete so today I begin with a low dose of israpidine and will titrate up to the level in the study, 10 mg daily. Meanwhile I am keeping an eye on other calcium blockers to be trialed.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.